Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118813) titled 'Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment' on Aug. 5.

Study Type: Observational

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Condition: Renal Cell Carcinoma (Kidney Cancer)

Recruitment Status: Recruiting

Date of First Enrollment: August 2025

Target Sample Size: 400

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118813

Published by HT Digital Content Services with permission from Health Daily Digest....